Taro Pharmaceutical
TARO
#5055
Rank
NZ$2.79 B
Marketcap
NZ$74.38
Share price
0.00%
Change (1 day)
9.34%
Change (1 year)

Taro Pharmaceutical (TARO) - Total assets

Total assets on the balance sheet as of December 2023 : NZ$3.74 Billion

According to Taro Pharmaceutical's latest financial reports the company's total assets are NZ$3.74 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Taro Pharmaceutical - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2023-03-31NZ$3.40 B8.64%
2022-03-31NZ$3.13 B-8.93%
2021-03-31NZ$3.44 B-12.39%
2020-03-31NZ$3.93 B25.72%
2019-03-31NZ$3.12 B-6.95%
2018-03-31NZ$3.36 B3%
2017-03-31NZ$3.26 B3.27%
2016-03-31NZ$3.16 B35.46%
2015-03-31NZ$2.33 B57.67%
2014-03-31NZ$1.48 B12.05%
2013-03-31NZ$1.32 B
2011-12-31NZ$1.01 B41.38%
2010-12-31NZ$0.72 B-9.03%
2009-12-31NZ$0.79 B-2.74%
2008-12-31NZ$0.81 B29.19%
2007-12-31NZ$0.63 B4.68%
2006-12-31NZ$0.60 B-24.84%
2005-12-31NZ$0.80 B-17.87%
2004-12-31NZ$0.97 B2.97%
2003-12-31NZ$0.94 B30.67%
2002-12-31NZ$0.72 B-2.07%
2001-12-31NZ$0.74 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$361.31 B 9,549.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 5,888.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 8,813.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$68.99 B 1,742.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$142.73 B 3,712.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$185.71 B 4,859.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland